MAP awarded ‘Accredited Facilitator’ status for latest NICE META Tool

MAP has recently been approved by NICE as one of a limited number of qualified META facilitators. NICE has developed the MedTech Early Technical Assessment (META) tool to help companies identify what evidence they currently have and make them aware of the evidence that payers, commissioners and investors may need in order to understand the value that their technology offers to patients and healthcare systems.

Click here to read our META announcement.

To find out more and get involved please click here.

Tagged with

Published 20. February 2018 in MAP Newsletters, News, News UK